home / stock / akba / akba news

AKBA News and Press, Akebia Therapeutics Inc. From 11/10/25

Stock Information
Company Name: Akebia Therapeutics Inc.
Stock Symbol: AKBA
Market: NASDAQ
Website: akebia.com
Menu
Get AKBA Alerts

News, Short Squeeze, Breakout and More Instantly...
AKBA - Akebia signals 7x increase in patient access for Vafseo entering 2026 amid operational focus

2025-11-10 11:02:38 ET More on Akebia Akebia Therapeutics, Inc. (AKBA) Q3 2025 Earnings Call Transcript Akebia Therapeutics: Dialysis-Only Path Puts VOCAL/Protocol Wins At The Core Akebia Therapeutics, Inc. (AKBA) Presents at Wells Fargo 20th Annual Healthcare Confer...
AKBA - Akebia GAAP EPS of $0.00 beats by $0.01, revenue of $58.78M beats by $2.36M

2025-11-10 07:09:01 ET More on Akebia Akebia Therapeutics: Dialysis-Only Path Puts VOCAL/Protocol Wins At The Core Akebia Therapeutics, Inc. (AKBA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript Akebia Therapeutics: Post-Earnings Dip Looks ...

AKBA - Akebia Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Vafseo ® (vadadustat) Q3 2025 net product revenues grew to $14.3 million ; Q3 2025 total net product revenues were $56.8 million Operational pilot of Vafseo at DaVita expected to complete in the fourth quarter; Access for 275,000 total patients across customer base ex...

AKBA - Expected US Company Earnings on Monday, November 10th, 2025

VEON Ltd. (VEON) is expected to report $1.21 for Q3 2025 eToro Group Ltd. (ETOR) is expected to report $0.52 for Q3 2025 KE Holdings Inc American Depositary Shares (each representing three Class A) (BEKE) is expected to report $0.09 for Q3 2025 CoreWeave Inc. (CRWV) is expected to rep...
AKBA - Here are the major earnings before the open Monday

2025-11-09 18:00:29 ET Major earnings expected before the bell on Monday include: Organon & Co. ( OGN ) Starwood Property Trust ( STWD ) Tyson Foods ( TSN ) Global Ship Lease ( GSL ) EVgo ( EVGO ) Read the full article on Seeking Alpha ...

AKBA - Akebia Q3 2025 Earnings Preview

2025-11-07 10:29:25 ET More on Akebia Akebia Therapeutics: Dialysis-Only Path Puts VOCAL/Protocol Wins At The Core Akebia Therapeutics, Inc. (AKBA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript Akebia Therapeutics: Post-Earnings Dip Looks ...

AKBA - Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs

CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the presentation of a post-hoc win odds analysis of all-cause mortal...
AKBA - Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights

CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the third quarter ended September 30, 2025, on Monday, November 10, 2025, prior to the open of financial markets. Akebia will...

AKBA - Akebia Therapeutics: Dialysis-Only Path Puts VOCAL/Protocol Wins At The Core

2025-10-29 13:38:23 ET Overview Akebia Therapeutics’ stock ( AKBA ) is reeling following the announcement that it intends not to pursue VALOR or a broad U.S. non-dialysis (NDD) label for Vafseo.... Read the full article on Seeking Alpha For further details...

AKBA - US Companies Moving the Markets, Morning edition
Wed, Oct 29, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Cambium Networks Corporation (CMBM) rose 270.6% to $2.29 on volume of 218,383,326 shares Purple Biotech Ltd. (PPBT) rose 95.5% to $1.14 on volume of 186,196,940 shares Profusa Inc. (PFSA) rose 27.2% to $0.36895 on volume of 117,196,177 ...
Previous 10 Next 10